First Manhattan
AST.WS

First Manhattan’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

First Manhattan’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-26
Closed – – 1566
2017
Q2 		$0 Hold
26
– – ﹤0.01% 1535
2017
Q1 		$0 Hold
26
– – ﹤0.01% 1514
2016
Q4 		$0 Hold
26
– – ﹤0.01% 1522
2016
Q3 		$0 Hold
26
– – ﹤0.01% 1547
2016
Q2 		$0 Buy
+26
New +$14 ﹤0.01% 1596

First Manhattan's AST.WS Position: Q3 2017 in Review

First Manhattan sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 26 shares.

First Manhattan first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • First Manhattan reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • First Manhattan sold 26 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • First Manhattan first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • First Manhattan's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on First Manhattan's 13F filing for Q3 2017, filed 25 Oct 2017.